A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia

Condition:   2019-nCoV Pneumonia Interventions:   Drug: ASC09F+Oseltamivir;   Drug: Ritonavir+Oseltamivir;   Drug: Oseltamivir Sponsor:   Tongji Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials